CStone Pharma Replaces Chairman Amid Huge Losses, Irregular Investment
CStone’s executive reshuffle comes after company discovers questionable investment made by finance vice president in 2021 Key Takeaways: CStone brought four products to market last year, and its losses have…
RELATED ARTICLES
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK -
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
No respite for RemeGen as problems and losses pile up
9995.HK 688331.SHG
- Innogen Pharma jostles for a slice of the weight-loss market
